This brand name is authorized in Australia, New Zealand
The drug BENZTROP contains one active pharmaceutical ingredient (API):
|
1
Benzatropine
UNII WMJ8TL7510 - BENZTROPINE MESYLATE
|
|
Benzatropine possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N04AC01 | Benzatropine | N Nervous system → N04 Anti-parkinson drugs → N04A Anticholinergic agents → N04AC Ethers of tropine or tropine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2362H |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 11277 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
